Delta Lloyd’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-7,335
Closed -$465K 635
2013
Q3
$465K Sell
7,335
-2,500
-25% -$158K 0.02% 346
2013
Q2
$413K Buy
+9,835
New +$413K 0.02% 355